Form 4 for TMDX TransMedics Group, Inc.
Accepted 2024-02-27 00:00:00 ET · period of report 2024-02-23 · accession 0000950170-24-021334 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-27 | 2024-02-23 | TMDX | Gordon Stephen | CFO | A - Grant | $0.00 | +12.1K | 25.2K | +93% | $0 |
| D | 2024-02-27 | 2024-02-23 | TMDX | Gordon Stephen | CFO | A - Grant | $0.00 | +18.7K | 18.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-23 | A | A | 12,127 | $0.00 | 25,202 | D | — | — | (F1) Consists of 12,127 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-02-23 | A | A | 18,690 | $0.00 | 18,690 | D | $83.14 · — to 2034-02-23 | 18,690 Common Stock | (F2) The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 23, 2024 until the option is fully vested on February 23, 2028, subject to continued service. |